Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gian Life CareBOM:542918 -0.41%59 OCF Yield % is 5.58 as of Aug. 06, 2026, which is 67% below its 10-year median of 17.14. GuruFocus rates BOM:542918 with a GF Score™ of 59/100 and a GF Value™ of ₹5.88 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Gian Life Care ranks better than 72.3% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Gian Life Care's OCF Yield % or its related term are showing as below:
BOM:542918'
s OCF Yield % Range Over the Past 10 Years
Min: 3.56 Med: 17.14 Max: 32.04
Current: 5.58
During the past 7 years, the highest OCF Yield % of Gian Life Care was 32.04%. The lowest was 3.56%. And the median was 17.14%.
BOM:542918's OCF Yield % is ranked better than 72.3% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.14
vs BOM:542918: 5.58
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Gian Life Care OCF Yield % Related Terms
Gian Life Care OCF Yield % Historical Data
* Premium members only.
The historical data trend for Gian Life Care's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542918 vs TMO, DHR, IDXX: OCF Yield % Comparison
For the Diagnostics & Research subindustry, Gian Life Care's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gian Life Care OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Gian Life Care's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Gian Life Care's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gian Life Care (BOM:542918) has a OCF Yield % of 5.58 as of Aug. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Gian Life Care and its competitors. This is 67% below median its historical median of 17.14. Over the past decade, Gian Life Care's OCF Yield % has ranged from 3.56 to 32.04. According to the industry distribution chart, Gian Life Care ranks #59 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 27.7%.
Is Gian Life Care's OCF Yield % too high?
Gian Life Care's current OCF Yield % of 5.58 is 67% below median its 10-year median of 17.14. Over the past 10 years, this metric has ranged from a low of 3.56 to a high of 32.04. The Medical Diagnostics & Research industry median OCF Yield % is 1.14. Gian Life Care's value of 5.58 is 389.5% above this industry median. Based on the distribution chart, Gian Life Care ranks #59 out of 213 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Gian Life Care has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gian Life Care's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Gian Life Care ranks #59 out of 213 companies for OCF Yield %. This puts Gian Life Care in the upper half of its industry. The industry median OCF Yield % is 1.14. Gian Life Care's value of 5.58 is 389.5% above this benchmark. Historically, Gian Life Care's own OCF Yield % has ranged from 3.56 to 32.04 over the past decade. While the company's 10-year median is 17.14 vs. the industry median of 1.14, Gian Life Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.14, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gian Life Care's current OCF Yield % of 5.58 is 389.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Gian Life Care and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gian Life Care's current OCF Yield % is 5.58, which is 67% below median its own 10-year median of 17.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gian Life Care stock overvalued right now?
Based on GuruFocus' analysis, Gian Life Care (BOM:542918) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹5.88, compared to a current price of ₹4.91 — trading 16.5% below its estimated fair value. The current OCF Yield % is 5.58, which is 67% below median its 10-year median of 17.14 and 389.5% above the Medical Diagnostics & Research industry median of 1.14. Gian Life Care's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Gian Life Care (BOM:542918), the current OCF Yield % is 5.58 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gian Life Care (BOM:542918) Overvalued in 2026?
Based on GuruFocus' analysis, Gian Life Care stock appears to be undervalued.
The current stock price of ₹4.91 is trading 16.5% below its estimated GF Value™ of ₹5.88.
GuruFocus considers Gian Life Care to be Modestly Undervalued.
Key valuation signals for BOM:542918:
OCF Yield %: 5.58 (67% below median its 10-year median of 17.14)
GF Value™: ₹5.88 vs. price of ₹4.91 (16.5% below fair value)
Industry Position: 389.5% above the Medical Diagnostics & Research median (#59 of 213)
No single metric tells the full story. See the BOM:542918 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gian Life Care Ltd is an Indian firm engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. The company provides a broad range of diagnostic and related healthcare tests and services such as patient diagnosis, prevention, and wellness diagnosis services to its patients and healthcare providers. Its customers include individual patients, hospitals, other healthcare providers, and corporate customers. Substantial revenue accrues from the Pathological Testing Fees. The company has only one operating segment namely, Laboratories Pathological Investigations.
59GF Score
Get the complete analysis for BOM:542918
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542918 has been successfully added to your 
